v3.25.2
Condensed Statements Of Cash Flows - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cashflow from Operating Activities:                
Net Income (loss) $ (511,758) $ (98,559) $ 1,681,247 $ 334,529 $ (610,317) $ 2,015,776    
Adjustments to reconcile net income to net cash used in operating activities:                
Change in fair value of Warrant Liability 290,250   (580,500)   290,250 290,250    
Interest earned on marketable securities held in trust         (275,203) (2,819,294)    
Changes in operating assets and liabilities:                
Prepaid expenses         (98,840) 139,782    
Accounts payable and accrued expenses         (267,200) (118,517)    
Due to Sponsor         (140,233) 8,052    
Net cash used in operating activities         (1,101,543) (483,951)    
Cash Flows from Investing Activities:                
Cash deposited in Trust Account         (200,000) (600,000)    
Investments withdrawn from Trust Account for payment to redeeming shareholders         17,521,050 0    
Net cash provided by (used in) investing activities         17,321,050 (600,000)    
Cash Flows from Financing Activities:                
Payment to Redeeming Shareholders (17,521,050)       (17,521,050) 0 $ (95,447,584) $ (172,774,717)
Proceeds from convertible promissory note - Sponsor         200,000 1,080,000    
Proceeds from working capital loan – Sponsor         1,046,172 0    
Net cash (used in) provided by financing activities         (16,274,878) 1,080,000    
Net Change in Cash         (55,371) (3,951)    
Cash - Beginning of period   $ 1,032,598   $ 276,777 1,032,598 276,777 276,777  
Cash - End of period $ 977,227   $ 272,826   977,227 272,826 $ 1,032,598 $ 276,777
Non-cash investing and financing activities                
Accretion of Class A ordinary shares subject to possible redemption         $ 475,203 $ 3,419,293